BREAKING: CDC investigates death of Virginia woman who died after getting the Johnson & Johnson vaccine last month
- A woman in Virginia died in March after being given Johnson & Johnson vaccine
- The news was announced on Tuesday, as the CDC called for a halt in their jab
- The CDC said that six people had suffered from blood clots after J&J’s vaccine
- More than 6.8 million people have received J&J’s vaccine in the United States
- The CDC is meeting on April 14 to review the evidence and reassess J&J
Virginia is stopping using Johnson & Johnson’s COVID vaccine after a woman died following her vaccination in March.
The Centers for Disease Control and Prevention (CDC) is investigating the woman’s death, Virginian health authorities announced on Tuesday.
News of her death, and Virginia’s decision to stop using the J&J vaccine, came on the day the CDC advised a pause in the use of the company’s jabs.
Their recommendation was made after six patients, out of the 6.8 million to receive the jab so far, reported blood clots.
A woman in Virginia has died after receiving in March the Johnson & Johnson COVID vaccine
The patients were all women aged 18-48, who suffered a cerebral venous sinus thrombosis (CVST) six to 13 days after receiving the jab.
It is still too early to tell whether or not the vaccine even caused the blood clots and it is a one in a million side effect.
Five times as many people have died from COVID-19 in the U.S. as they do from blood clots ever year.
The agencies, however, say they want to do more tests and studies and that it could take days for them decide on whether or not to resume it.
They may impose a restriction on the vaccine based on the demographic of people who have developed blood clots – all of them are women under 50.
The White House on Tuesday tried to smooth over the sudden halt of the Johnson and Johnson COVID-19 vaccine, claiming it would not affect their goals to vaccinate the U.S. – despite health experts saying it clearly sets back the country’s rollout.
President Joe Biden said in the Oval Office on Tuesday: ‘I made sure we have 600 million doses of the mRNA – not of either Johnson & Johnson or AstraZeneca.
‘So, there is enough vaccine that is basically 100 per cent unquestionable for every single solitary American,’ he said.
Pfizer said it was ramping up production by 10 per cent in light of the J&J halt.
Now, it says it will deliver 220 million doses by the end of May.
The U.S. has only fully vaccinated 28 per cent of its population.
It is behind Israel, Bahrain and Chile, all of which have considerably smaller economies and populations.
When counting just how many first vaccine doses have been given out, the UK is third in the world after Israel and Chile and the U.S. is fifth rather than fourth.
Around one million people a week (142,857 a day) are receiving the J&J vaccine.
It is considerably less than the number receiving Pfizer and Moderna doses (5million a week, 714,285 a day).
Advertisement
